2023 Q4 Results for Neutrino RPM Phase I.

Neutrino Medical, Inc. completed a pilot project with enrollment of 25 heart failure patients post discharge in Q4 of 2016. Over the 3 months monitoring period, one patient ( 1/25) was readmitted for observation due to a malfunctioning lifeVest. Patients expressed satisfaction with the ease of use in responding to the survey questions. Medication reminder tool drove up the compliance of therapy. Patients even requested access to the app after the monitoring period ended.

Neutrino Medical Inc. is excited with the results of the initial pilot project. Our future plans include Phase II patient enrollment and monitor over a period of three months.